AIM To recognize the characteristic findings of non pathologic perfusion defects with CT arterial portography (CTAP) and nonpathologic enhancement found in CT hepatic arteriography (CTHA). METHODS The manifestatio...AIM To recognize the characteristic findings of non pathologic perfusion defects with CT arterial portography (CTAP) and nonpathologic enhancement found in CT hepatic arteriography (CTHA). METHODS The manifestations of nonpathologic perfusion defects with CTAP and non pathologic enhancement found in CTHA were analyzed in 50 patients with primary hepatocellular carcinoma. RESULTS The false positive rate of perfusion defects detected in CTAP was 15 1%. The shapes of perfusion defects were peripheral wedge, small, round, and patchy. The occurrence rate of non pathologic enhancement found in CTHA was 22 0%. The shapes of non pathologic enhancement were small, round, irregular, and wedge. CONCLUSION There was a high frequency of non pathologic perfusion defects detected with CTAP and non pathologic enhancement found in CTHA. The simultaneous use of both procedures may help decrease the false positive rate, and increase the veracity of diagnosis for hepatocellular carcinoma.展开更多
文摘AIM To recognize the characteristic findings of non pathologic perfusion defects with CT arterial portography (CTAP) and nonpathologic enhancement found in CT hepatic arteriography (CTHA). METHODS The manifestations of nonpathologic perfusion defects with CTAP and non pathologic enhancement found in CTHA were analyzed in 50 patients with primary hepatocellular carcinoma. RESULTS The false positive rate of perfusion defects detected in CTAP was 15 1%. The shapes of perfusion defects were peripheral wedge, small, round, and patchy. The occurrence rate of non pathologic enhancement found in CTHA was 22 0%. The shapes of non pathologic enhancement were small, round, irregular, and wedge. CONCLUSION There was a high frequency of non pathologic perfusion defects detected with CTAP and non pathologic enhancement found in CTHA. The simultaneous use of both procedures may help decrease the false positive rate, and increase the veracity of diagnosis for hepatocellular carcinoma.